109 related articles for article (PubMed ID: 2500559)
1. Morphological analysis of iliac crest bone biopsies in patients with osteoporosis and treatment according to the ADFR concept with (1-38)hPTH and diphosphonate (EHDP)--Osteoporosis Study I, Hannover.
Delling G; Dreyer T; Vogel M; Hahn M; Rittinghaus EF; Hesch RD
Klin Wochenschr; 1989 May; 67(10):556. PubMed ID: 2500559
[No Abstract] [Full Text] [Related]
2. [Morphologic study of iliac crest spongiosa in patients with osteoporosis treated according to the ADFR (activation, depression of resorption, formation, repeat the cycle) with parathyroid hormone and diphosphonates (Hannover PTH I study)].
Delling G; Dreyer T; Hahn M; Vogel M; Rittinghaus EF; Hesch RD
Z Orthop Ihre Grenzgeb; 1990; 128(1):1-5. PubMed ID: 2138378
[TBL] [Abstract][Full Text] [Related]
3. Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1-38)hPTH and diphosphonate EHDP. Protocol of study I, osteoporosis trial Hannover.
Hesch RD; Heck J; Delling G; Keck E; Reeve J; Canzler H; Schober O; Harms H; Rittinghaus EF
Klin Wochenschr; 1988 Oct; 66(19):976-84. PubMed ID: 3141672
[TBL] [Abstract][Full Text] [Related]
4. [Morphologic study of iliac crest spongiosa in patients with osteoporosis treated with combination therapy of pulsatile administration of parathyroid hormone (1-38 hPTH) and sequential addition of calcitonin nasal spray].
Vogel M; Hesch RD; Delling G
Med Klin (Munich); 1990 Feb; 85(2):82-6. PubMed ID: 2319988
[TBL] [Abstract][Full Text] [Related]
5. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.
Dempster DW; Cosman F; Kurland ES; Zhou H; Nieves J; Woelfert L; Shane E; Plavetić K; Müller R; Bilezikian J; Lindsay R
J Bone Miner Res; 2001 Oct; 16(10):1846-53. PubMed ID: 11585349
[TBL] [Abstract][Full Text] [Related]
6. hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses.
Reeve J; Bradbeer JN; Arlot M; Davies UM; Green JR; Hampton L; Edouard C; Hesp R; Hulme P; Ashby JP
Osteoporos Int; 1991 Jun; 1(3):162-70. PubMed ID: 1790404
[TBL] [Abstract][Full Text] [Related]
7. Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy.
Reeve J; Arlot M; Bernat M; Charhon S; Edouard C; Slovik D; Vismans FJ; Meunier PJ
Metab Bone Dis Relat Res; 1981; 3(1):23-30. PubMed ID: 7266363
[No Abstract] [Full Text] [Related]
8. [Therapy of osteoporosis using the ADFR schedule (especially with parathyroid hormone and etidronate)].
Ziegler R
Internist (Berl); 1991 Feb; 32(2):76-9. PubMed ID: 1903362
[No Abstract] [Full Text] [Related]
9. Preliminary observations of a form of coherence therapy for osteoporosis.
Anderson C; Cape RD; Crilly RG; Hodsman AB; Wolfe BM
Calcif Tissue Int; 1984 May; 36(3):341-3. PubMed ID: 6432299
[TBL] [Abstract][Full Text] [Related]
10. Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1-38) and salmon calcitonin in osteoporotic patients.
Hodsman AB; Steer BM; Fraher LJ; Drost DJ
Bone Miner; 1991 Jul; 14(1):67-83. PubMed ID: 1868270
[TBL] [Abstract][Full Text] [Related]
11. Human parathyroid peptide treatment of vertebral osteoporosis.
Reeve J; Arlot ME; Bradbeer JN; Hesp R; Mcally E; Meunier PJ; Zanelli JM
Osteoporos Int; 1993; 3 Suppl 1():199-203. PubMed ID: 8461559
[TBL] [Abstract][Full Text] [Related]
12. Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate.
Durchschlag E; Paschalis EP; Zoehrer R; Roschger P; Fratzl P; Recker R; Phipps R; Klaushofer K
J Bone Miner Res; 2006 Oct; 21(10):1581-90. PubMed ID: 16995813
[TBL] [Abstract][Full Text] [Related]
13. Treatment of postmenopausal osteoporotic women with parathyroid hormone 1-84 for 18 months increases cancellous bone formation and improves cancellous architecture: a study of iliac crest biopsies using histomorphometry and micro computed tomography.
Fox J; Miller MA; Recker RR; Bare SP; Smith SY; Moreau I
J Musculoskelet Neuronal Interact; 2005; 5(4):356-7. PubMed ID: 16340137
[No Abstract] [Full Text] [Related]
14. Iliac crest biopsy in longitudinal therapeutic trials of osteoporosis.
Pødenphant J; Riis BJ; Johansen JS; Leth A; Christiansen C
Bone Miner; 1988 Oct; 5(1):77-87. PubMed ID: 3214682
[TBL] [Abstract][Full Text] [Related]
15. Osteoporosis: cause and management.
Anderson DC
Br Med J (Clin Res Ed); 1987 Apr; 294(6578):1032-3. PubMed ID: 3119006
[No Abstract] [Full Text] [Related]
16. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.
Reeve J; Davies UM; Hesp R; McNally E; Katz D
BMJ; 1990 Aug; 301(6747):314-8. PubMed ID: 2393738
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
[TBL] [Abstract][Full Text] [Related]
18. Intermittent administration of the circulating form of human parathyroid hormone (hPTH-1-37) prevents bone loss in ovariectomized rats.
Stephan S; van de Flierdt J; Loumi S; Bonaterra G; Kramer FJ; Fehr M; Tillmann HC; Forssmann WG; Maronde E
Eur J Med Res; 2007 Jan; 12(1):13-20. PubMed ID: 17363353
[TBL] [Abstract][Full Text] [Related]
19. A small dose of human parathyroid hormone(1-34) increased bone mass in the lumbar vertebrae in patients with senile osteoporosis.
Sone T; Fukunaga M; Ono S; Nishiyama T
Miner Electrolyte Metab; 1995; 21(1-3):232-5. PubMed ID: 7565456
[TBL] [Abstract][Full Text] [Related]
20. A simple method for correlative light and scanning electron microscopy of human iliac crest bone biopsies: qualitative observations in normal and osteoporotic subjects.
Dempster DW; Shane E; Horbert W; Lindsay R
J Bone Miner Res; 1986 Feb; 1(1):15-21. PubMed ID: 3503529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
